These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

974 related items for PubMed ID: 17156986

  • 1. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL, Rauth AM, Bendayan R, Wu XY.
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [Abstract] [Full Text] [Related]

  • 2. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY.
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL, Bendayan R, Rauth AM, Wu XY.
    J Control Release; 2006 Dec 01; 116(3):275-84. PubMed ID: 17097178
    [Abstract] [Full Text] [Related]

  • 4. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY.
    Breast Cancer Res Treat; 2010 Jan 01; 119(2):255-69. PubMed ID: 19221875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin.
    Liu H, Xu H, Wang Y, He Z, Li S.
    Drug Dev Ind Pharm; 2012 Sep 01; 38(9):1031-8. PubMed ID: 22794192
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES, Na K, Bae YH.
    J Control Release; 2005 Mar 21; 103(2):405-18. PubMed ID: 15763623
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP.
    J Control Release; 2010 Dec 20; 148(3):359-67. PubMed ID: 20854859
    [Abstract] [Full Text] [Related]

  • 10. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J, Park K, Kim YS, Kim MS, Han JK, Kim K, Park RW, Kim IS, Song HK, Lee DS, Kwon IC.
    J Control Release; 2007 Nov 06; 123(2):109-15. PubMed ID: 17894942
    [Abstract] [Full Text] [Related]

  • 11. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY, Rauth AM, Ronaldson PT, Bendayan R, Wu XY.
    Eur J Pharm Biopharm; 2006 Apr 06; 62(3):321-31. PubMed ID: 16330194
    [Abstract] [Full Text] [Related]

  • 12. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice.
    Al-Abd AM, Hong KY, Song SC, Kuh HJ.
    J Control Release; 2010 Feb 25; 142(1):101-7. PubMed ID: 19819274
    [Abstract] [Full Text] [Related]

  • 14. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I.
    Int J Pharm; 2008 Nov 03; 363(1-2):170-6. PubMed ID: 18687392
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ, Liu LN, Du YZ, Yuan H.
    Biomaterials; 2009 Dec 03; 30(36):6955-63. PubMed ID: 19782395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 18. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
    Shuhendler AJ, Prasad P, Zhang RX, Amini MA, Sun M, Liu PP, Bristow RG, Rauth AM, Wu XY.
    Mol Pharm; 2014 Aug 04; 11(8):2659-74. PubMed ID: 24830351
    [Abstract] [Full Text] [Related]

  • 19. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles.
    Kim TH, Mount CW, Gombotz WR, Pun SH.
    Biomaterials; 2010 Oct 04; 31(28):7386-97. PubMed ID: 20598741
    [Abstract] [Full Text] [Related]

  • 20. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM, Devarajan PV.
    Int J Pharm; 2012 Feb 28; 423(2):554-61. PubMed ID: 22155412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.